Skip Navigation


European Heart Journal Advance Access originally published online on March 29, 2007
European Heart Journal 2007 28(10):1258-1264; doi:10.1093/eurheartj/ehm011
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
28/10/1258    most recent
ehm011v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in EHJ
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Theiss, H. D.
Right arrow Articles by Franz, W.-M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Theiss, H. D.
Right arrow Articles by Franz, W.-M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The European Society of Cardiology 2007. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Circulation of CD34+ progenitor cell populations in patients with idiopathic dilated and ischaemic cardiomyopathy (DCM and ICM)

Hans D. Theiss1, Robert David1, Markus G. Engelmann1, Andreas Barth1, Klaus Schotten2, Michael Naebauer1, Bruno Reichart3, Gerhard Steinbeck1 and Wolfgang-M. Franz1,*

1 Medical Department I, Ludwig Maximilians University, Klinikum Grosshadern, Marchioninistr, 15, 81377 Munich, Germany
2 Institute of Medical Informatics, Biometry and Epidemiology (IBE), Ludwig Maximilians University, Klinikum Grosshadern, Munich, Germany
3 Department of Heart Surgery, Ludwig Maximilians University, Klinikum Grosshadern, Munich, Germany

Received 16 May 2006; revised 6 February 2007; accepted 15 February 2007; online publish-ahead-of-print 29 March 2007.

* Corresponding author. Tel: +49 89 7095 6095; fax: +49 89 7095 6094. E-mail address: wolfgang.franz{at}med.uni-muenchen.de

See page 1180 for the editorial comment on this article (doi:10.1093/eurheartj/ehm155)

Aims: This study aimed at analysing the endogenous stem cell circulation in patients suffering from idiopathic dilated cardiomyopathy (DCM) and ischaemic cardiomyopathy (ICM).

Methods and results: Cytokines in peripheral blood were analysed using enzyme-linked immunosorbent assay and circulating CD34+ stem cell populations (CD34+CD133+, CD34+CD31+, CD34+CXCR-4+) were measured by flow cytometry in DCM patients (n = 25), ICM patients (n = 15), and controls (n = 10). Explanted DCM (n = 5), ICM (n = 4) and normal hearts (n = 5) were analysed for the expression of several homing factors [stromal cell-derived factor-1 (SDF-1), Stem cell factor (SCF), HIF-1a, vascular cell adhesion molecule (VCAM), and Hepatocyte growth factor] by quantitative real-time polymerase chain reaction (PCR). SDF-1 was significantly elevated and positively correlated with brain natriuretic peptide (BNP) in peripheral blood of DCM and ICM patients showing the same New York heart association- (NYHA) class. In DCM patients circulating CD34+ cell populations were significantly increased in comparison to ICM patients and controls. mRNA of SDF-1, SCF, HIF-1a, and VCAM related to glyceraldehyde-3-phosphate dehydrogenase was significantly upregulated in ICM hearts when compared with DCM hearts and controls.

Conclusion: Myocardial homing factors are upregulated in ICM when compared with DCM hearts. Reduced homing of stem cells might therefore explain the increased number of CD34+ cells in DCM patients. These findings may open a new insight into the pathology and the treatment of idiopathic DCM.

Key Words: Dilated cardiomyopathy • Heart failure • Progenitor cell • Stem cell • Mobilization • Homing


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related articles in EHJ:

The stem cell army in heart failure: do we mobilize or pave the way home?
Jacob Joseph
EHJ 2007 28: 1180-1181. [Extract] [Full Text]  



This article has been cited by other articles:


Home page
Therapeutic Advances in Cardiovascular DiseaseHome page
T. J. Povsic and P. J. Goldschmidt-Clermont
Review: Endothelial progenitor cells: markers of vascular reparative capacity
Therapeutic Advances in Cardiovascular Disease, June 1, 2008; 2(3): 199 - 213.
[Abstract] [PDF]


Home page
Eur Heart JHome page
J. Joseph
The stem cell army in heart failure: do we mobilize or pave the way home?
Eur. Heart J., May 2, 2007; 28(10): 1180 - 1181.
[Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.